This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting set for 5 November 2026 results review
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board will meet on 5 November 2026 to consider unaudited financial results and a limited review report for the quarter and half-year ended 30 September 2026. The notice does not disclose any financial figures or performance details.
A results update may follow, but the notice provides no numbers, so the possible effect on the share price cannot be assessed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹3.54 Cr | ₹0.00 Cr | turned positive |
| Operating profit | ₹0.05 Cr | −₹0.21 Cr | turned positive |
| Profit after tax | ₹0.05 Cr | −₹0.21 Cr | turned positive |
| EBITDA margin | 4.6% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.